Interferon-alpha-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-alpha alone: an Italian multicenter, randomized, controlled, clinical study.

Interferon-alpha-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-alpha alone: an Italian multicenter, randomized, controlled, clinical study.

Item
http://www.wikidata.org/entity/Q42537483
Retreatment of hepatitis C non-responsive to interferon. A placebo controlled randomized trial of ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378]Chronic viral hepatitis C: management updateRibavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivoMeta-analysis: combination therapy with interferon-alpha 2a/2b and ribavirin for patients with chronic hepatitis C previously non-responsive to interferon.Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C.High-dose interferon-alpha2b induction therapy in combination with ribavirin for treatment of chronic hepatitis C in patients with non-response or relapse after interferon-alpha monotherapy.Efficacy of high-dose interferon in combination with ribavirin in patients with chronic hepatitis C resistant to interferon alone.Changes in serum levels of hepatitis C virus genotype 1b monitored by real-time quantitative polymerase chain reaction as a predictor of long term response to interferon-alpha treatment.Impact of high-dose interferon induction and ribavirin therapy in patients with chronic hepatitis C relapsing after or not responding to interferon monotherapy.High-dose prolonged combination therapy in non-responders to interferon monotherapy for chronic hepatitis C.Interferon-alpha plus ribavirin for 12 months increases the sustained response rates in chronic hepatitis C relapsers.Low daily dosage of interferon for 1 year after HCV-related end-therapy response. A randomized-controlled study.Treatment of chronic hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. The Virginia Cooperative Hepatitis Treatment Group.Cost-effectiveness analysis of therapeutic strategies for patients with chronic hepatitis C previously not responding to interferon.Treatment with ribavirin and interferon-alpha reduces interferon-gamma expression in patients with chronic hepatitis C.
P2860

Interferon-alpha-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-alpha alone: an Italian multicenter, randomized, controlled, clinical study.

Item
http://www.wikidata.org/entity/Q42537483
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Interferon-alpha-2B and ribavi ...... d, controlled, clinical study.
@en
Interferon-alpha-2B and ribavi ...... d, controlled, clinical study.
@nl
type
label
Interferon-alpha-2B and ribavi ...... d, controlled, clinical study.
@en
Interferon-alpha-2B and ribavi ...... d, controlled, clinical study.
@nl
prefLabel
Interferon-alpha-2B and ribavi ...... d, controlled, clinical study.
@en
Interferon-alpha-2B and ribavi ...... d, controlled, clinical study.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Interferon-alpha-2B and ribavi ...... d, controlled, clinical study.
@en
P2093
P304
P31
P356
10.1016/S0002-9270(98)00583-8
P407
P433
P478
P577
P698
P921